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Objectives: To describe the history, clinicopathological abnormalities, diagnostic imaging findings, 
lymph node cytological/histological appearance, treatment and outcome of English springer spaniels 
diagnosed with idiopathic pyogranulomatous lymphadenitis.
Materials and MethOds: In this retrospective UK-based multicentre study, 64 dogs were recruited from 
10 referral centres, 32 first-opinion practices and three histopathology/cytology laboratories, between 
2010 and 2016.
results: The median age at presentation was 6 years (range: 0.17 to 11.75). Neutered females were 
frequently affected. Pyrexia (83.8%), peripheral lymphadenomegaly (78.4%), dermatological lesions 
(72.9%), lethargy (67.6%), hyporexia (54%), diarrhoea (29.7%), coughing (24.3%), epistaxis, sneezing 
or nasal discharge (21.6%), ocular signs (21.6%) and vomiting (16.2%) were reported in dogs for 
which the history and physical examination records were available. Popliteal (45.3%), superficial 
cervical (35.9%) and submandibular (37.5%) lymphadenomegaly were frequently reported. 
Haematology and serum biochemistry revealed non-specific changes. When undertaken, testing for 
infectious diseases was negative in all cases. Lymph node cytology, histopathology or both demon-
strated mixed inflammatory (27%), pyogranulomatous (24%), neutrophilic (20%) or granulomatous 
(11%) lymphadenitis. Treatment details were available for 38 dogs, with 34 receiving prednisolone for 
a median duration of 15 weeks (range: 1 to 28 weeks). A good to excellent clinical response was 
reported in all but one case. Ten dogs relapsed after discontinuing prednisolone.
clinical significance: Idiopathic pyogranulomatous lymphadenitis should be considered as a differential 
diagnosis for lymphadenopathy and pyrexia in English springer spaniels. The characteristics of the 
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disease, absence of identifiable infectious aetiology and response to glucocorticoid therapy suggest 
an immune-mediated aetiology.
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INTRODUCTION
Pyogranulomatous lymphadenitis refers to inflammation of 
the lymph nodes, involving inflammatory infiltration by mac-
rophages and neutrophils (Raskin 2016). This type of inflam-
matory response is often triggered by stimuli such as infectious 
agents or foreign material (Zumla & James 1996, Greene 2012). 
Although infectious diseases are strong differentials for pyo-
granulomatous lymphadenitis, many cases of sterile pyogranu-
lomatous lymphadenitis have been described in young and adult 
dogs, often associated with cutaneous lesions sharing similar 
histological or cytological features (Reimann et al. 1989, White 
et al. 1989, Jeffers et al. 1995, Neuber et al. 2004, Bassett et al. 
2005, Scott & Miller 2007, O’Kell et al. 2010, Dandrieux et al. 
2011, McPartland et al. 2016, Fraga-Manteiga et al. 2016, Mar-
tens 2016). Mineral-associated lymphadenopathy has also been 
described as an uncommon cause of sterile pyogranulomatous 
lymphadenitis in which deposition of complex mineral crystals 
in the peripheral lymph nodes initiates an intense granulomatous 
inflammation and lymphadenopathy (Day 1996).
In dogs, idiopathic pyogranulomatous lymphadenitis (IPGL) 
is a diagnosis of exclusion and thus other causes of pyogranulo-
matous lymphadenitis must be ruled out. In particular, infectious 
aetiologies must be excluded before starting immunosuppressive 
treatment. Multiple agents have been identified to cause pyogranu-
lomatous inflammation, including bacteria [Actinomyces, Barton-
ella (Pappalardo et al. 2000, Pappalardo et al. 2001, Saunders & 
Monroe 2006, Morales et al. 2007, Tucker et al. 2014, Drut et al. 
2014), Mycobacterium, Nocardia and Staphylococcus], fungi (Asper-
gillus, Blastomyces, Coccidioides, Cryptococcus, Histoplasma), oomy-
cetes (Pythium) and protozoa (Neospora, Toxoplasma, Leishmania) 
(Mylonakis et al. 2005, Greene 2012). Other infectious agents 
associated with granulomatous and pyogranulomatous lymphad-
enitis have also been recently reported, such as Rhodococcus equi 
(Bryan et al. 2017), Sporotrichum pruinosum (Magstadt et al. 
2018), Cladosporium cladosporioides-complex (Spano et al. 2018), 
Talaromyces helicus (Tomlinson et al. 2011), Chrysosporium species 
(Cook et al. 2016), Scytalidium (Dunlap et al. 2015), Paracoccidioi-
des brasiliensis (Headley et al. 2017) and circovirus (Li et al. 2013).
Several related clinical entities have been described, including 
“canine juvenile cellulitis,” “canine sterile nodular panniculitis” 
and “sterile idiopathic neutrophilic-macrophagic lymphadenitis.” 
Canine juvenile cellulitis is characterised by cutaneous and/or sub-
cutaneous pyogranulomatous lesions with systemic involvement 
and pyogranulomatous lymphadenitis (Reimann et al. 1989, White 
et al. 1989, Bassett et al. 2005, Scott & Miller 2007, Dandrieux 
et al. 2011, Fraga-Manteiga et al. 2016, Martens 2016). The onset 
of the disease can occur from a very early age, the youngest case 
reported being 4 weeks old (Scott & Miller 2007), although similar 
cases have been reported in adult dogs (Jeffers et al. 1995, Neuber 
et al. 2004, Scott & Miller 2007,O’Kell et al. 2010, McPartland 
et al. 2016), and the terms “canine sterile nodular panniculitis” 
or “sterile idiopathic neutrophilic-macrophagic lymphadenitis” 
have been used to describe these conditions and their presumed 
non-infectious aetiology (O’Kell et al. 2010, McPartland et al. 
2016). Additionally, localised foci of sterile pyogranulomatous 
inflammation within epidural, subcutaneous or intra-abdominal 
fat have been reported in a few dogs without systemic involvement 
(German et al. 2003, Aikawa et al. 2008, Nishida et al. 2012). 
Although the relationship between these different clinical entities 
remains unknown, the similarities between the clinicopathologic 
manifestations may suggest a common origin.
IPGL has been recognised for years in several breeds (McPart-
land et al. 2016), including English springer spaniels (ESSs) 
(Dandrieux et al. 2011, McPartland et al. 2016, Fraga-Manteiga 
et al. 2016). This disease is characterised by the enlargement of 
more than one peripheral or internal lymph node, with cytologic 
examination demonstrating necrosis, and a spectrum of suppu-
rative/neutrophilic, pyogranulomatous or pure granulomatous 
inflammation. Diagnosis is made by excluding infectious, inflam-
matory or neoplastic causes. The aetiology is poorly understood, 
and screening for infectious causes is usually unrewarding. An 
immune-mediated aetiology has been postulated, because most 
dogs have a good clinical response to glucocorticoids or other 
immunosuppressive treatment.
A detailed description of the disease in dogs has not been pub-
lished. Although a case-series suggested a high prevalence of the 
disease in ESSs (McPartland et al. 2016, Ribas Latre et al. 2019), 
a comprehensive description of the disease in this breed has not 
been published. Thus, the aim of this retrospective study was to 
describe the history, clinicopathological abnormalities, diagnos-
tic imaging findings, lymph node histological/cytological and 
outcome of ESS with IPGL.
MATERIALS AND METHODS
Cases were primarily recruited from 10 referral centres in the UK 
between 2010 and 2015. A smaller number of cases were also 
recruited from 22 first-opinion practices, one histopathology 
and two cytology laboratories. A project outline with a request 
for cases was published in two veterinary journals (Bexfield et al. 
2015a, Bexfield et al. 2015b) and on the (UK-based) Small Ani-
mal Medicine Society (SAMSoc) website (http://www.vetsur-
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geon.org/Associations/samsoc/f/64/t/23122.aspx). Clinicians or 
laboratories who agreed to participate in this study were asked to 
submit details of signalment, clinical signs, physical examination 
findings and the location of affected lymph node(s) along with 
lymph node and cutaneous or subcutaneous lesion cytological 
and/or histological findings. Additionally, they were requested 
to submit test results for infectious disease screening on faeces, 
blood, urine or other body fluids along with the results of all 
imaging (including the modality used). Information on the drug, 
dosage and duration of treatment(s) was also submitted along 
with the response to treatment, adverse effects of treatment and 
long-term outcome, if available.
Criteria for inclusion in this study were as follows: (1) ESS; 
(2) lymphadenopathy involving more than one peripheral 
and/or internal lymph node; (3) lymph node cytology or his-
tology results demonstrating neutrophilic, pyogranulomatous 
or predominantly granulomatous inflammation. If available, 
categorical data were collected, anonymised and entered into 
a spreadsheet (Microsoft Excel). Each category was presented 
descriptively with percentages. Cases were excluded if an under-
lying infectious or neoplastic disease was identified. Continuous 
data including age, treatment dosage and duration of treatment 
were recorded. For each parameter, median and/or mean ±sd and 
range were calculated. The age recorded was the age to the near-
est month when each dog first presented with clinical signs of 
IPGL. The relationship of the disease with gender and neuter 
status was explored using a chi-squared test. For all comparisons, 
significance was set at P<0.05.
RESULTS
Gender and age distribution
Sixty-four ESSs satisfied the inclusion criteria and were included 
in the study. Ten of these dogs were included in another 
retrospective study that described canine pyogranulomatous 
lymphadenitis in several breeds (Ribas Latre et al. 2019).
Of our 64 cases, 25 were neutered females, 19 were neu-
tered males, 12 were entire females and eight were entire males 
(Table 1). The median age at diagnosis was 6 years (72 months) 
with dogs ranging from 2 months to 14 years (Fig. 1). There was 
no apparent gender (P=0.25) or neuter (P=0.8) predisposition 
in this small sample. However, when the four groups were com-
pared (females, neutered females, males, neutered males), neu-
tered female dogs were statistically over-represented (P=0.02).
History and clinical signs
History and physical examination records were available in 37 
cases. Information about vaccination status and travel history 
were not available. The most common clinical signs reported 
by owners were dermatological abnormalities (n=27; 72.9%), 
lethargy (n=25; 67.6%) and decreased appetite (n=20, 54%). 
Reported dermatological abnormalities included single or mul-
tiple skin masse(s) (n=8), ulcerated or alopecic skin lesions (n=3), 
facial swelling (n=2), ventral cervical swelling (n=2), skin ery-
thema (n=2), other localised swelling (n=2), erythematous and 
pruritic pinnae (n=2) and purulent skin lesions (n=1). Clinical 
signs suggestive of nasal disease were reported in six cases (16.2%), 
including nasal discharge (n=4), sneezing (n=2) and epistaxis 
(n=2). In total, gastrointestinal signs including diarrhoea (n=11), 
vomiting (n=6), ptyalism (n=2), dysphagia (n=1) and flatulence 
(n=1) were reported in 21 (56.7%) cases. Respiratory signs were 
also reported, these included coughing (n=9; 24.3%) and dys-
pnoea or tachypnoea (n=4; 10.8%). Less frequently reported 
signs included weight loss, lameness (two cases each; 5.4%) and 
polydipsia (one case; 2.7%) (Fig. 2).
Physical examination
Physical examination on admission revealed pyrexia (range: 39.3 
to 40.7°C) in 31 of 37 (83.8%) cases. Peripheral lymphadeno-
megaly was noted in 29 of 37 cases (78.4%), including popliteal 
(n=29), superficial cervical (n=24), submandibular (n=23) and 
retropharyngeal (n=12) lymphadenomegaly (Fig. 3). Jaundice 
was reported in one dog.
Cardiorespiratory examination and auscultation identified 
increased inspiratory noise in two dogs, low-grade cardiac mur-
murs in three dogs, sinus bradycardia in one dog and a cardiac 
arrhythmia in one dog. Abdominal palpation was abnormal in 
three dogs, with evidence of abdominal discomfort, splenomeg-
aly or hepatomegaly each identified in one dog (Table 2).
Dermatological abnormalities reported on initial physi-
cal examination included: subcutaneous or cutaneous masses 
(n=8), oral ulcers (n=4), facial swelling (n=2), ventral cervical 
swelling (n=2), cutaneous pustules (n=2), localised subcutane-
ous swelling (n=2), otitis (n=2), ulcerated cutaneous lesions 
on the face (n=1), thoracic limbs (n=1), bridge of the nose 
(n=1), and prepuce (n=1), alopecic cutaneous lesion with 
hyperpigmentation and lichenification (n=1), seborrhoea on 
both pinnae (n=1), and suppurative cutaneous lesion (n=1). 
Unilateral testicular enlargement was reported in one case 
(Table 2).
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FIG 1. Age distribution in 64 ESSs diagnosed with IPGL
Table 1. Gender distribution in 64 ESSs diagnosed with 
IPGL
Gender Number of dogs Percentage
Female neutered 25 39.1
Female entire 12 18.8
Male neutered 19 29.6
Male entire 8 12.5
Total 64 100
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FIG 3. Anatomical distribution of lymphadenopathy in 37 ESSs diagnosed 
with IPGL
Table 2. Response to treatment in 38 ESSs diagnosed with 
IPGL
Response treatment 
modalities
Excellent Good Partial Poor Total
Prednisolone alone 13 4 0 0 17
Prednisolone+antibiotics* 4 4 1 0 9
Prednisolone+other 
immunosuppressive drug(s)†
4 2 0 0 6
Prednisolone+other 
immunosuppressive 
drug(s)†+antibiotics*
1 1 0 0 2
Antibiotics alone 0 0 0 4 4
Total 22 11 1 4 38
*Metronidazole, doxycycline, amoxicillin/clavulanic acid, enrofloxacin, cephalexin
†Azathioprine and/or ciclosporin
and ruptured corneal ulcer (n=1). One dog had absent tear pro-
duction bilaterally (Table 2).
Orthopaedic examination revealed right pelvic limb lameness 
in one case and bilateral pelvic limb lameness with bilateral stifle 
effusion in one case (Table 2).
Neurological abnormalities were identified in five dogs. One 
dog had head tremor, one dog had unilateral facial nerve paraly-
sis and one dog had unilateral facial paralysis with concurrent 
neurological abnormalities suggestive of lower motor neuron 
(LMN) disease in the right pelvic limb. One dog had mandibular 
paralysis, suggestive of trigeminal nerve disease, and a history of 
seizures was reported in the remaining dog (Table 2).
Clinical pathology
Haematology and serum biochemistry
Results of complete blood count were available in 34 cases. 
Abnormalities were documented in 24 cases (70.5%), and were 
classified as mild-to-moderate by the clinical pathologist. The 
most commonly encountered haematological abnormality was 
neutrophilia (n=12), occasionally associated with left shift (n=3), 
followed by leucocytosis (n=8), monocytosis (n=6), non-regener-
ative anaemia (n=6), lymphopenia (n=3), leucopenia (n=2), lym-
phocytosis (n=1), eosinophilia (n=1) and thrombocytosis (n=1).
Results of serum biochemistry were available in 26 cases 
and abnormal results were noted in 11 (42.3%). These changes 
included increases in alkaline phosphatase activity (n=8), hyper-
cholesterolaemia (n=4) and hypoalbuminaemia (n=4). Increases 
in alanine amino transferase activity (n=2), total hypercalcaemia 
(n=2), total hypocalcaemia (n=1), hyperbilirubinaemia (n=1), 
hypertriglyceridaemia (n=1) and azotaemia (n=1) were also 
reported.
Infectious diseases screening
Tests for infectious diseases were undertaken in 18 dogs.
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FIG 2. Distribution of clinical signs reported at presentation in 37 ESSs diagnosed with IPGL
Ophthalmological abnormalities included bilateral conjuncti-
val hyperaemia (n=2), unilateral conjunctival hyperaemia (n=1), 
unilateral mucopurulent ocular discharge (n=1), uveitis (n=1), 
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Serology was performed for Borrelia burgdorferi (n=10), 
Ehrlichia canis and ewingii (n=5), Anaplasma phagocytophilum 
and platys (n=4), Leptospira species (n=3), Brucella canis (n=1), 
Bartonella species (n=1) and Leishmania species (n=1). Dirofilaria 
immitis antigenaemia (n=4), Babesia species PCR on whole blood 
(n=1), Angiostrongylus vasorum antigenaemia (n=1), Mycobacte-
rium species PCR (n=4) and Bartonella hanselae PCR (n=3) on 
lymph node aspirates or biopsy were also performed. All infec-
tious diseases testing results were negative except for Leptospira 
species serology that was consistent with recent vaccination in 
one dog (serology positive with a titre of 200 for L. canicola and 
L. copenhagi).
Bacterial cultures were negative from a variety of body fluids, 
including: urine (n=8), faeces (n=4), cerebrospinal fluid (CSF; 
n=3), blood (n=2), bronchoalveolar lavage fluid (n=2), endotra-
cheal fluid (n=1), joint fluid (n=1) and pericardial fluid (n=1). 
Bacterial culture from lymph node biopsy was performed in 12 
cases and all results were negative.
Cutaneous lesion histology and cytology
Biopsy and cytology results of cutaneous lesions revealed necro-
tising/pyogranulomatous panniculitis (n=2), pyogranulomatous 
panniculitis (n=2), pyogranulomatous/granulomatous pannicu-
litis (n=2), pyogranulomatous dermatitis (n=1), granulomatous 
dermatitis (n=2), pyogranulomatous perifolliculitis (n=1), neu-
trophilic and necrotising cellulitis (n=1), pyogranulomatous 
cellulitis (n=1), cellulitis (n=1), panniculitis (n=1) and multiple 
lipomas (n=1).
Lymph node histology and cytology
In total, 71 lymph nodes were sampled: biopsy and histopa-
thology on 41 (57.7%) and fine needle aspiration cytology 
on 30 (42.3%). Lymph node cytology and histology results 
 demonstrated a spectrum of necrotising, suppurative/neutro-
philic, pyogranulomatous-to-predominantly granulomatous 
lymphadenitis. Among the main different inflammatory cat-
egories, the most common features identified were pyogranulo-
matous (n=17; 24% of the lymph nodes sampled), followed by 
suppurative/neutrophilic (n=14; 20%) and granulomatous (n=8; 
11%) inflammation. A combination of the different inflamma-
tory features was identified in 19 lymph nodes sampled (27%), 
including pyogranulomatous/granulomatous lymphadenitis 
(n=6), pyogranulomatous/necrotising lymphadenitis (n=4), sup-
purative and necrotising lymphadenitis (n=1), granulomatous, 
necrotising and sclerosing lymphadenitis (n=1), lymphocytic, 
suppurative and plasmacytic lymphadenitis (n=1), necrotising, 
suppurative and pyogranulomatous lymphadenitis (n=1), suppu-
rative/pyogranulomatous lymphadenitis (n=1) and eosinophilic/
histiocytic lymphadenitis (n=1). Lymph node cytology or histol-
ogy results were unremarkable or yielded non-specific findings 
including lymphoplasmacytic inflammation, reactive hyperpla-
sia, eosinophilic lymphadenitis or necrotising lymphadenitis, 
in six lymph nodes (7% of lymph nodes). Lymph node analysis 
also included Ziehl Neelsen (ZN) and Periodic acid-Schiff (PAS) 
stains on lymph nodes aspirate cytology. Gram stain and exami-
nation under polarised light to exclude mineral-associated disease 
were undertaken on 25 lymph nodes.
Other investigations
Arthrocentesis of multiple joints was performed in two dogs with 
joint effusion, lameness or both. In these two cases, cytology of 
the joint fluid revealed sterile neutrophilic inflammation, sugges-
tive of immune-mediated polyarthritis. In one dog, CSF cytol-
ogy revealed moderate mixed pleocytosis. In another dog, brain 
MRI was consistent with meningoencephalitis and CSF cytology 
revealed marked neutrophilic pleocytosis. In the same dog, bron-
choalveolar lavage and pericardial fluid cytology revealed pyo-
granulomatous inflammation. One dog was identified to have 
Table 3. Physical abnormalities at presentation in 37 ESSs diagnosed with IPGL
Dermatological abnormalities Ophthalmological 
abnormalities
Cardiorespiratory 
abnormalities
Neurological 
abnormalities
Palpation 
abnormalities
Orthopaedic 
abnormalities
Subcutaneous or cutaneous 
masses (n=8)
Facial swelling (n=2), ventral 
cervical swelling (n=2), 
localised subcutaneous 
swelling (n=2)
Oral ulcers (n=4)
Ulcerated cutaneous lesions 
on the face (n=1), forelimbs 
(n=1), bridge of the nose 
(n=1), and prepuce (n=1)
Cutaneous pustules (n=2)
Otitis (n=2)
Alopecic cutaneous lesion 
with hyperpigmentation and 
lichenification (n=1)
Seborrhoea on both pinnae 
(n=1)
Suppurative cutaneous lesion 
(n=1)
Bilateral conjunctival 
hyperaemia (n=2)
Unilateral conjunctival 
hyperaemia (n=1)
Unilateral mucopurulent 
ocular discharge (n=1)
Uveitis (n=1)
Ruptured corneal ulcer 
(n=1)
Absence of tear 
production bilaterally 
(n=1)
Low-grade cardiac 
murmurs (n=3)
Increased inspiratory 
noise (n=2)
Sinus bradycardia (n=1)
Cardiac arrhythmia (n=1)
Head tremor (n=1)
Unilateral facial nerve 
paralysis (n=1)
Unilateral facial 
paralysis with LMN 
deficits on the right 
hind limb (n=1)
Mandibular paralysis 
(n=1)
Testicular 
enlargement (n=1)
Abdominal 
discomfort (n=1)
Splenomegaly (n=1)
Hepatomegaly (n=1)
Right hind-limb 
lameness (n=1)
Bilateral hind limb 
lameness with 
bilateral stifle 
effusion (n=1)
IPGL idiopathic pyogranulomatous lymphadenitis, ESS English springer spaniels, LMN lower motor neuron
C. Dor et al.
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splenic and hepatic nodules, diagnosed by histopathology to be 
eosinophilic/granulomatous splenitis and eosinophilic, lympho-
cytic, histiocytic hepatitis, respectively.
Radiography was the most widely used imaging modality 
(n=21), followed by abdominal ultrasound (n=20). Intra-tho-
racic lymphadenopathy was diagnosed in five dogs by thoracic 
radiography. Intra-abdominal lymphadenopathy was detected 
in nine dogs by abdominal ultrasonography. Intra-abdominal 
lymph node sampling was undertaken when accessible. Ultra-
sonographic assessment of the cervical area undertaken in four 
dogs confirmed the presence of lymphadenopathy in three dogs. 
Lymphadenopathy was detected in six dogs on CT imaging and 
in three dogs on MRI.
Distribution of enlarged lymph nodes
Data regarding the type and/or the number of lymph nodes 
affected was available for 56 dogs. Based on clinical examina-
tion and diagnostic imaging, popliteal (n=28; 50%), superfi-
cial cervical (n=24; 42.9%) and submandibular (n=23; 41.1%) 
lymphadenomegaly were frequently reported. Less commonly, 
retropharyngeal (n=12; 21.4%), intra-thoracic (n=9; 16.1%) and 
inguinal (n=6; 10.7%) lymphadenomegaly were also identified. 
Interestingly, intra-thoracic and/or intra-abdominal lymphad-
enomegaly, with no visible or palpable peripheral lymphadeno-
megaly, was diagnosed by thoracic and/or abdominal imaging in 
eight cases (Fig. 3).
The number of enlarged lymph nodes varied. Only one pair 
of lymph nodes (left and right) was enlarged in most cases (n=25, 
44.7%). Two pairs of lymph nodes were enlarged in 15 cases 
(26.8%), three pairs of lymph nodes in 10 cases (17.9%) and 
four or more pairs of lymph nodes in six cases (10.7%).
Treatment and outcome
Prediagnosis treatment and outcome
Details about treatment administered before diagnosis were 
available in 27 cases. Eighteen cases received antibiotics and non-
steroidal anti-inflammatory drugs (NSAID). Eight cases received 
antibiotics alone and one case received antibiotics and a dose of 
0.5 mg/kg prednisolone once daily concurrently. Anti-inflam-
matory drugs used included robenacoxib, meloxicam, carprofen, 
and tolfedine. Antibiotics used included cephalexin, cefuroxime, 
doxycycline, amoxicillin clavulanate, metronidazole, amoxicillin, 
marbofloxacin, enrofloxacin, pradofloxacin, trimethoprim/sul-
fadimethoxine, clindamycin, spiramycin/metronidazole and oxy-
tetracycline. In most cases, dogs received two or more antibiotics 
simultaneously. In all cases, there had been no improvement in 
clinical signs including rectal temperature and lymphadenopathy.
Treatment and outcome after diagnosis
Details relating to medical management were available in 38 
cases. Thirty-four (89.5%) of these dogs were prescribed pred-
nisolone, and the remaining four were treated with antibiotics 
alone, including co-amoxicillin/clavulanate, doxycycline and/
or enrofloxacin. Of the 34 cases treated with glucocorticoids, 
concurrent antibiotics were administered in 12 dogs (35.3%). A 
variety of other supportive medications were also used, includ-
ing sucralfate, omeprazole, ranitidine, tramadol, misoprostol, 
paracetamol, maropitant and mirtazapine. These drugs were 
administered by primary clinicians based on initial clinical signs.
Data regarding the dose and treatment duration of predniso-
lone therapy was available in 33 out of 34 cases. The daily dose 
of prednisolone (mg per dog) was available in 20 cases and the 
exact prednisolone dosage (mg/kg) was available for 13. The 
mean and median starting doses of prednisolone were 27.5 mg/
day (daily dose) or 2 mg/kg/day (exact dosage). Among the 33 
dogs with available data regarding prednisolone, three received a 
constant daily dose, while the dose was tapered in the remaining 
30 dogs. The median duration of initial prednisolone treatment 
was 21 days (range: 2 to 120) and the median duration of the 
full prednisolone course was 15 weeks (range: 1 to 28) in both 
groups of dogs receiving constant and decreasing doses. Of the 
34 cases that had been given prednisolone, 11 (32.4%) had been 
given antibiotics at the same time. Among cases which received 
prednisolone at an immunosuppressive dose, other immunosup-
pressive treatments were given in eight cases, including doses of 
2 mg/kg azathioprine orally once daily (n=7) or 5 mg/kg azathio-
prine and ciclosporin orally once daily (n=1) (Table 3). Azathio-
prine and cyclosporine treatment durations were not available in 
most dogs. Treatment outcome was recorded as partial, good or 
excellent in the notes from the referring veterinarians.
In dogs treated with prednisolone (n=34), an excellent 
response was recorded in 22 cases (64.7%), a good response in 
11 (32.4%) and a partial response in one (2.9%). Of the four 
cases that had been given antibiotics only, no improvement was 
reported in any of them (Table 3).
Relapse was suspected in 10 dogs (10 of 38, 26.3%) with recur-
rent lethargy, nasal discharge, lymph node enlargement (periph-
eral or intra-abdominal) and pyrexia. In two dogs, lymph nodes 
were re-aspirated and cytology results revealed similar features as 
previously documented. The time of relapse after discontinua-
tion of the glucocorticoids and/or information regarding repeat 
treatment was not available in three cases. In the remaining seven 
cases, all dogs relapsed after finishing the course of prednisolone. 
The median interval till relapse after cessation of prednisolone 
was 13 weeks (range: 2 to 52 weeks). Re-initiation of predniso-
lone therapy was recommended in eight cases. Adjunctive immu-
nosuppressants were also recommended in two dogs: a dose of 
2 mg/kg azathioprine orally once daily and then every other day 
in one case, and a combination dose of 2 mg/kg azathioprine 
orally once daily and 5 mg/kg ciclosporin orally once daily in the 
other case. One dog (11.1%) was not treated and recovered spon-
taneously. Two dogs relapsed for a second time at 10 months and 
1 year after discontinuation of the second course of treatment 
(prednisolone and azathioprine, prednisolone alone respectively). 
No long-term follow-up information was available for these two 
dogs.
Overall, four dogs were euthanased and one dog died second-
ary to colonic necrosis and septic peritonitis. Euthanasia was the 
result of absent or poor response to treatment after multiple epi-
sodes of recurrence (n=1), recurrence of the disease after tapering 
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the dose of glucocorticoids (n=1), onset of monoparesis second-
ary to development of a lumbar spinal mass (n=1) and worsening 
of chronic coughing with marked adverse side effects of gluco-
corticoids (n=1).
DISCUSSION
This retrospective study provides the largest description of IPGL 
in the ESS. In a multi-breed retrospective study describing the 
disease in 49 dogs, ESSs appeared over-represented (16 of 49) 
(Ribas Latre et al. 2019). Given the number of cases recruited in 
this retrospective study over a 5-year time period and given the 
percentage of ESSs in the previously mentioned study, this breed 
appears predisposed to IPGL. Therefore, IPGL should be consid-
ered as part of the differential diagnosis for lymphadenopathy in 
all dogs, but particularly in this breed. Further investigations may 
be required to confirm this assumption. In this study, the median 
age at the time of diagnosis was 6 years, which compares with a 
median of 3.75 years reported previously in all breeds (Ribas Latre 
et al. 2019). Neutered female dogs were frequently affected. It 
remains unclear whether there might be a breed-variant of IPGL 
in ESSs, or whether a breed predisposition exists in ESSs. The pos-
sibility of a true sex predisposition may also warrant further inves-
tigations. ESSs with IPGL show many non-specific clinical signs 
at presentation, similar to those previously reported in all breeds 
(McPartland et al. 2016, Fraga-Manteiga et al. 2016), and most 
appear to show signs of a systemic or multi-organ inflammatory 
process. Major signs including skin lesions, lethargy and decreased 
appetite were reported in more than half of the dogs. Diarrhoea, 
epistaxis, sneezing or nasal discharge, coughing, ocular changes 
and vomiting were less common. On physical assessment, pyrexia 
and lethargy were identified in more than three-quarters of the 
dogs. Although none of these signs were pathognomonic of IPGL, 
the combination of dermatological lesions, pyrexia and lymphade-
nopathy should raise suspicion of the disease in this breed.
In this study, peripheral lymphadenomegaly predominantly 
affected the popliteal, superficial cervical and sub-mandibular 
lymph nodes. In most cases, only one pair of lymph nodes was 
enlarged. Although most cases of lymphadenomegaly were iden-
tified on physical examination, imaging identified intra-thoracic 
and/or intra-abdominal lymphadenomegaly with no evident 
peripheral lymphadenopathy in eight dogs. This finding empha-
sises that lymph node lesions should not be ruled out based on 
palpation of peripheral lymph nodes alone. In addition to their 
usual role in screening for any underlying infectious or neoplas-
tic diseases, thoracic radiography and abdominal ultrasonogra-
phy appear to be cost-effective first-line imaging modalities for 
detecting internal lymphadenomegaly.
While coughing or abnormal respiratory patterns were reported 
in a quarter of cases, thoracic imaging was often of low-yield with 
respect to identifying the cause of respiratory signs. In our study, 
thoracic CT revealed abnormalities in two dogs, one with a dif-
fuse bronchointerstitial pattern and the other with a nodular pul-
monary pattern. A similar clinical presentation was reported in a 
9-month ESS with idiopathic PGL (Fraga-Manteiga et al. 2016), 
but in that case, thoracic radiographs were unremarkable. Simi-
larly, while vomiting and diarrhoea were reported in a quarter of 
cases, abdominal imaging was frequently unremarkable. Among 
the 17 dogs with gastrointestinal signs, diffuse small intestinal 
wall thickening was identified in only one dog, and thickening 
of the descending colon with altered wall layering was identified 
in another dog. Although no gastrointestinal disease was iden-
tified in our study, lymphoplasmacytic colitis and pancreatitis 
have previously been described in dogs with sterile nodular pan-
niculitis (O’Kell et al. 2010), and could have contributed to the 
gastrointestinal signs reported by some owners, especially consid-
ering that clinicopathological testing and diagnostic imaging are 
poorly sensitive for both of these diseases. Ptyalism, dysphagia 
and oral ulcers were reported in four cases. Interestingly, these 
findings have not been described in previous publications.
There was a combination of pyrexia, abnormalities of multiple 
organ systems and neutrophilia in most dogs, which may be sug-
gestive of a systemic inflammatory process. Evidence of concur-
rent inflammatory disease was detected in four cases, including 
polyarthritis, mild pericardial effusion, bronchial inflammation, 
splenic and hepatic pyogranulomatous nodules, meningoenceph-
alitis and CSF pleocytosis. However, the relationship between 
these findings and IPGL remains unclear. Although polyarthritis 
has been described in dogs with canine sterile nodular panniculi-
tis (O’Kell et al. 2010), the relationship between IPGL and other 
concurrent inflammatory processes requires further investigation.
Before diagnosis, most dogs received either a combination of 
NSAID and antibiotics or antibiotic therapy alone. In all cases, 
there was no improvement reported. Following diagnosis, pred-
nisolone was the most commonly used drug, either alone or in 
combination with ciclosporin or azathioprine. A good to excellent 
response to treatment was noted in almost all cases. These results 
are similar to two retrospective studies and one case report of sterile 
panniculitis, in which the vast majority of dogs were successfully 
treated with immunosuppressive drugs (Yamagishi et al. 2007, 
O’Kell et al. 2010, Santoro & Campbell 2011). The absence of 
obvious infectious triggers and the good-to-excellent response to 
glucocorticoids might suggest an immune-mediated aetiology. In 
our study, patients received long courses of prednisolone, alone or 
in combination with other immunosuppressive drugs or antibiot-
ics. Relapse(s) occurred in a quarter of cases following cessation of 
treatment, suggesting the need for long term, and perhaps even 
life-long, immunosuppressive therapy in some individuals.
Due to the retrospective nature of this study, and because some 
cases were recruited directly from histopathology laboratories, 
diagnostic and outcome data were missing in a large number of 
cases. This may represent the main limitation of our study. Con-
sidering the extensive range of possible infectious aetiologies, a 
further limitation of this study is the absence of systematic infec-
tious disease screening in all dogs. Data regarding travel history 
was also missing. Considering the low prevalence of infectious 
diseases in the UK, and the good-to-excellent response to immu-
nosuppressive therapy, an infectious aetiology seems unlikely. 
Although these conclusions may be applicable to the UK canine 
population, systemic screening for infectious diseases responsible 
for pyogranulomatous lymphadenitis is strongly recommended 
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in other parts of the world. Specific diseases, such as leishmani-
asis, need to be systematically ruled out in endemic areas.
In conclusion, although the aetiology of the disease is poorly 
understood, an immune-mediated process is strongly suspected, 
and therapy with prednisolone appears effective. The response 
to immune-suppressive treatment is usually good but long-term 
courses of immunosuppressive drugs are often required and 
relapses are frequent.
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